Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients

GP Fadini, M Rigato, F Boscari, R Cappellari… - Vascular …, 2015 - Elsevier
Abstract Type 2 diabetes (T2D) is characterized by impaired vascular regeneration owing to
reduced endothelial progenitor cells (EPCs). While statins are known to increase EPCs, the …
被引用次数：21 相关文章

Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients.

G Fadini, M Rigato, F Boscari… - VASCULAR …, 2014 - research.unipd.it
Type 2 diabetes (T2D) is characterized by impaired vascular regeneration owing to reduced
endothelial progenitor cells (EPCs). While statins are known to increase EPCs, the effects of …

Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients

GP Fadini, M Rigato, F Boscari, R Cappellari… - 2015 - pubmed.ncbi.nlm.nih.gov
Type 2 diabetes (T2D) is characterized by impaired vascular regeneration owing to reduced
endothelial progenitor cells (EPCs). While statins are known to increase EPCs, the effects of …

Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients

GP Fadini, M Rigato, F Boscari, R Cappellari… - Vascular …, 2015 - infona.pl
Type 2 diabetes (T2D) is characterized by impaired vascular regeneration owing to reduced
endothelial progenitor cells (EPCs). While statins are known to increase EPCs, the effects of …

Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients.

GP Fadini, M Rigato, F Boscari, R Cappellari… - Vascular …, 2014 - europepmc.org
Type 2 diabetes (T2D) is characterized by impaired vascular regeneration owing to reduced
endothelial progenitor cells (EPCs). While statins are known to increase EPCs, the effects of …